The qRT-PCR analysis suggested a longer half-life of circSPIRE1 in RCC cells compared to SPIRE1 mRNA after treatment with actinomycin D, a transcription inhibitor (Fig. S1I). This evidence concerns the gene SPIRE1 and renal cell carcinoma.